State
73,833 recalls have nationwide distribution and so reach Kansas. 5,822 additional recalls listed Kansas specifically in their distribution scope.
Of the 5,822 recalls naming Kansas we have scored against our rubric, 1,053 (18%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,486 (26%) are Severe.
Which agencies issued them
These figures cover only the 5,822 recalls whose distribution notice names Kansas specifically. The 73,833 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Siemens is recalling 42 units of Syngo Imaging XS software because printouts may be in incorrect anatomical size when using unsupported printers.
Ameditech is recalling Immutest 11 Pnl Drug Screen Cups because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling ProScreen 6 Panel Cup kits because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling Immutest Cup CLIA Waived kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling 120 DrugSmart Dip drug test kits because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling 10,320 CLIA RDTC 12-Panel Cup kits nationwide because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Boston Scientific is recalling IntellaTip MiFi XP catheters because the rate of distal tip bends and kinks exceeded anticipated levels during routine monitoring.
Boston Scientific is recalling IntellaTip MiFi XP catheters because the rate of distal tip bends and kinks exceeded anticipated levels during routine monitoring.
Becton Dickinson is recalling specific lots of Vancomycin Screen Agar because expired and in-date products may show breakthrough growth of vancomycin-susceptible Enterococcus faecalis near the end of shelf life.
Ameditech is recalling 96 kits of ProScProScreen 10 Panel Cups due to reduced reactivity for two benzodiazepine compounds.
Ameditech is recalling ProScreen CLIA Waived Cup kits because they may show reduced reactivity for two specific benzodiazepine compounds.
Philips Medical Systems is recalling 135 Ingenuity Core CT systems because a software upgrade may have restricted access to the basic axial perfusion feature for some users.
Ameditech is recalling ProScreen 12 Panel Cups because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Boston Scientific is recalling IntellaTip MiFi XP catheters because the rate of distal tip bends and kinks exceeded anticipated levels during routine monitoring.
Ameditech is recalling DrugSmart 11 Test Cups because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling DrugSmart Cup drug tests because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling ImmuTest 12 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Rainbow Specialty & Health Products is recalling Dressol-X and Dressit-X dental dressings because the labels do not list the percentage of drug components.
Ameditech is recalling DrugSmart 9 Test Cup kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling 340 DrugSmart 10 Test Cup kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ProScreen 12 Drug Cups because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling DrugSmart Cup 10 units because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling 492 ProScreen CLIA Waived Cup kits due to reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ProScreen 6 Panel Dip Drug Screen kits due to reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling 82 kits of ProScreen 8 Panel Dip Cards because they may show reduced reactivity for two specific benzodiazepine compounds.